Invega Sustenna Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials
• Forums

Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate
Condition:   SchizophreniaIntervention:   Sponsor:   Janssen Pharmaceutica N.V., BelgiumRecruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2015 Category: Research Source Type: clinical trials

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
Conditions:   Schizophrenia;   Psychotic DisordersInterventions:   Drug: Oral Antipsychotics (OAP);   Drug: Paliperidone Palmitate Injection (PP1M);   Drug: Paliperidone Palmitate Injection (PP3M)Sponsor:   Janssen Scientific Affairs, LLCNot yet recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2015 Category: Research Source Type: clinical trials